These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 1397812)

  • 1. Policy recommendations for pharmaceutical representative-resident interactions.
    Brotzman GL; Mark DH
    Fam Med; 1992 Aug; 24(6):431-2. PubMed ID: 1397812
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Policies regulating the activities of pharmaceutical representatives in residency programs.
    Brotzman GL; Mark DH
    J Fam Pract; 1992 Jan; 34(1):54-7. PubMed ID: 1728655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of residency program guidelines for interaction with the pharmaceutical industry. Education Council, Residency Training Programme in Internal Medicine, Department of Medicine, McMaster University, Hamilton, Ont.
    CMAJ; 1993 Aug; 149(4):405-8. PubMed ID: 8348422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interactions with the pharmaceutical industry: experiences and attitudes of psychiatry residents, interns and clerks.
    Hodges B
    CMAJ; 1995 Sep; 153(5):553-9. PubMed ID: 7641153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interactions of staff and residents with pharmaceutical industry: a survey of psychiatric training program policies.
    Chakrabarti A; Fleisher WP; Staley D; Calhoun L
    Ann R Coll Physicians Surg Can; 2002 Dec; 35(8 Suppl.):541-6. PubMed ID: 15015500
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Residents' perceptions over time of pharmaceutical industry interactions and gifts and the effect of an educational intervention.
    Schneider JA; Arora V; Kasza K; Van Harrison R; Humphrey H
    Acad Med; 2006 Jul; 81(7):595-602. PubMed ID: 16799279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interactions between pharmaceutical representatives and doctors in training. A thematic review.
    Zipkin DA; Steinman MA
    J Gen Intern Med; 2005 Aug; 20(8):777-86. PubMed ID: 16050893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A study of interactions between pharmaceutical representatives and ophthalmology trainees.
    Wang Y; Adelman RA
    Am J Ophthalmol; 2009 Oct; 148(4):619-622.e3. PubMed ID: 19570520
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of pharmaceutical company representatives on internal medicine residency programs. A survey of residency program directors.
    Lichstein PR; Turner RC; O'Brien K
    Arch Intern Med; 1992 May; 152(5):1009-13. PubMed ID: 1580704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A survey of the interactions between psychiatry residency programs and the pharmaceutical industry.
    Varley CK; Jibson MD; McCarthy M; Benjamin S
    Acad Psychiatry; 2005; 29(1):40-6. PubMed ID: 15772403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmaceutical representatives and emergency medicine residents: a national survey.
    Reeder M; Dougherty J; White LJ
    Ann Emerg Med; 1993 Oct; 22(10):1593-6. PubMed ID: 8214843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Council of Emergency Medicine Residency Directors position on interactions between emergency medicine residencies and the pharmaceutical industry.
    Keim S; Perina DG;
    Acad Emerg Med; 2004 Jan; 11(1):78. PubMed ID: 14709434
    [No Abstract]   [Full Text] [Related]  

  • 13. Are gifts from pharmaceutical companies ethically problematic? A survey of physicians.
    Brett AS; Burr W; Moloo J
    Arch Intern Med; 2003 Oct; 163(18):2213-8. PubMed ID: 14557219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect on resident attitudes of regulatory policies regarding pharmaceutical representative activities.
    Brotzman GL; Mark DH
    J Gen Intern Med; 1993 Mar; 8(3):130-4. PubMed ID: 8455108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Residency Curricula on Physician-Pharmaceutical Industry Interaction: A CERA Study.
    Evans DV; Waters RC; Olsen C; Stephens MB; Brown SR
    Fam Med; 2016 Jan; 48(1):44-8. PubMed ID: 26950665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Managing conflicts of interest in clinical care: the "race to the middle" at U.S. medical schools.
    Chimonas S; Evarts SD; Littlehale SK; Rothman DJ
    Acad Med; 2013 Oct; 88(10):1464-70. PubMed ID: 23969349
    [TBL] [Abstract][Full Text] [Related]  

  • 17. To what extent do educational interventions impact medical trainees' attitudes and behaviors regarding industry-trainee and industry-physician relationships?
    Carroll AE; Vreeman RC; Buddenbaum J; Inui TS
    Pediatrics; 2007 Dec; 120(6):e1528-35. PubMed ID: 18055668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Managing conflicts of interest in clinical care: a national survey of policies at U.S. medical schools.
    Chimonas S; Patterson L; Raveis VH; Rothman DJ
    Acad Med; 2011 Mar; 86(3):293-9. PubMed ID: 21248603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medical education and the pharmaceutical industry.
    Goodman RL
    Perspect Biol Med; 2007; 50(1):32-9. PubMed ID: 17259674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A population-based study of the prevalence and influence of gifts to radiation oncologists from pharmaceutical companies and medical equipment manufacturers.
    Halperin EC; Hutchison P; Barrier RC
    Int J Radiat Oncol Biol Phys; 2004 Aug; 59(5):1477-83. PubMed ID: 15275735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.